Plasma interleukin-6 is not a mediator of changes in lipoprotein lipase activity in cancer patients.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Hepato-Gastroenterology

• Publication date

  1997-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 9356883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor cytotoxicity and interleukin 1 production of blood monocytes of lung cancer patients

  2005cited by this paper
• Role of insulin resistance in decreasing lipoprotein lipase activity in tumor-bearing rats

  1996cited by this paper
• Effects of tumor removal and body weight loss on insulin resistance in patients with cancer.

  1994cited by this paper
• Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia.

  1992cited by this paper
• Cytokines and their role in the pathophysiology of cancer cachexia.

  1992cited by this paper
• Evidence for the involvement of interleukin 6 in experimental cancer cachexia.

  1992cited by this paper
• The role of cytokines in cancer cachexia.

  1992cited by this paper
• Tumor-induced alterations in tissue lipoprotein lipase activity and mRNA levels.

  1991cited by this paper
• Tumor necrosis factor-alpha and interleukin-1 alpha production in cachectic, tumor-bearing mice.

  1990cited by this paper
• Amino acid metabolism in human cancer cachexia.

  1990cited by this paper
• Cachectin/tumor necrosis factor and interleukin-1 show different modes of combined effect on lipoprotein lipase activity and intracellular lipolysis in 3T3-L1 cells.

  1989cited by this paper
• Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity.

  1989cited by this paper
• Cachectin activity in the serum of cachectic, tumor-bearing rats.

  1989cited by this paper
• Interleukin‐1 and tumor necrosis factor production by tumor‐associated mononuclear leukocytes and peripheral mononuclear leukocytes in cancer patients

  1988cited by this paper
• Whole body lipid and energy metabolism in the cancer patient.

  1987cited by this paper
• Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo.

  1987cited by this paper
• Effects of tumor bearing and removal on blood levels of lipids, lipolytic activity, and glycerol and on carcass weight in the rat.

  1987cited by this paper
• Regulation of lipoprotein lipase synthesis and 3T3-L1 adipocyte metabolism by recombinant interleukin 1.

  1986cited by this paper
• Reduced Plasma Lipoprotein Lipase Activity in Patients with Malignancy-Associated Weight Loss

  1986cited by this paper
• Relationships between the metabolism of high‐density and very‐low‐density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity

  1982cited by this paper
• Modified lipoprotein lipase activities, rates of lipogenesis, and lipolysis as factors leading to lipid depletion in C57BL mice bearing the preputial gland tumor, ESR-586.

  1981cited by this paper
• Enzymatic microdetermination of serum free fatty acids.

  1979cited by this paper
• Multilayer film elements for clinical analysis: applications to representative chemical determinations.

  1978cited by this paper
• A stable, radioactive substrate emulsion for assay of lipoprotein lipase.

  1976cited by this paper

• Lipid traits and lipid-lowering drug target genes and risk of melanoma: a mendelian randomization study

  2024cites this paper
• Deliberation on debilitating condition of cancer cachexia: Skeletal muscle wasting

  2023cites this paper
• The burning furnace: Alteration in lipid metabolism in cancer-associated cachexia

  2022cites this paper
• Metabolic Biomarkers for the Early Detection of Cancer Cachexia

  2021cites this paper
• Disturbances of Lipid Metabolism in a Cancer Cell and How This Knowledge Increases Its Role in Clinical Oncology

  2016cites this paper
• The role of triglyceride lipases in cancer associated cachexia

  2013cites this paper
• Lipid Transfer to HDL is Higher in Marathon Runners than in Sedentary Subjects, but is Acutely Inhibited During the Run

  2012cites this paper
• The growth of murine breast cancer cells in dystrophic mice

  2011influential citation
• Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis

  2008cites this paper
• LIPOPROTEIN LIPASE ACTIVITY AND GENE EXPRESSION IN LUNG CANCER AND IN ADJACENT NONCANCER LUNG TISSUE

  2007cites this paper
• Progestagens and Corticosteroids in the Management Cancer Cachexia

  2006cites this paper
• Lipid Metabolism in Cachexia

  2006cites this paper
• Pathophysiology of cancer cachexia.

  2000cites this paper